Concepedia

Author

Melissa Cheu

Centre Hospitalier Régional Universitaire de BrestORCID

Also Known As

M Cheu, M. Cheu, Melissa Cheu

22

Publications

817

Citations

10

H-Index

32

Concepts

All Affiliations

Centre Hospitalier Régional Universitaire de BrestUniversity of PennsylvaniaJohns Hopkins UniversityUniversity of GroningenMayo Clinic
MC

About

Melissa Cheu is an author at Centre Hospitalier Régional Universitaire de Brest specializing in medicine, pathology, and autoimmunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

177

2

Pathology

3

3

177

3

Immunology

2

2

144

4

Medical Laboratory Science

1

1

32

5

Molecular Medicine

1

1

33

Melissa Cheu

×

10

Publications

744

Citations

10

H-Index

YearCitations

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren,

Thorax

2015

374

Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material

Saloumeh K Fischer, Melissa Cheu, Kun Peng,

The AAPS Journal

2016

112

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

D.M. Chen, Adefowope Odueyungbo, Eva Csinady,

British Journal of Dermatology

2019

91

A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies

Gregory Z. Ferl, Arthur E. Reyes, Liping Sun,

Clinical and Translational Science

2018

35

Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma

Jia Ling, Roy S. Herbst, David S. Mendelson,

Journal of Clinical Oncology

2006

33

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

John R. Mills, Divi Cornec, Surendra Dasari,

Analytical Chemistry

2016

32

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis

Divi Cornec, Brian Kabat, John R. Mills,

Lara D. Veeken

2017

26

Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey

Christina L. Zuch de Zafra, Avi Ashkenazi, Walter C. Darbonne,

Cell Death and Disease

2016

21

Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy

Dana Lee Baker, Kun Peng, Melissa Cheu,

Current Medical Research and Opinion

2013

10

Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies

Rajbharan Yadav, Siddharth Sukumaran, Tanja S. Zabka,

Pharmaceutics

2022

10

Page 1